GSK3B and hepatocellular carcinoma: Our data clearly demonstrated that WM130 decreased the phosphorylation of GSK3β (Ser9) in HCC cells and tumor xenografts, suggesting that WM130-induced β-catenin degradation was possibly mediated by the activation of GSK3β.